AHA 2017 Wrap-Up in French

Dr. Gilles Montalescot and Dr. Mathieu Kerneis Present

AHA 2017 Wrap-Up from a Pacific Rim Perspective

Wrap-Up by Dr. Phil Aylward

AHA 2017 Wrap-Up from the Perspective of the Netherlands

Dr. Freek Verheugt Presents

AHA 2017 Wrap-Up in Arabic

Dr. Chadi Alraies Presents

AHA 2017 Wrap-Up in Portuguese

Dr. Renato Lopes Presents

GM- CSF and Supervised Exercise in PAD

Dr. C. Michael Gibson discusses the trial findings with Dr. Mary McDermott at AHA 2017.

Implementation of Evidence-Based Treatments in NSTEMI Outcomes

Dr. C. Michael Gibson discusses the trial findings with Dr. Karolina Szummer at AHA 2017

Transcatheter Inter-atrial Shunt Device for Treatment of HF

Dr. C. Michael Gibson discusses the trial findings with Dr. Sanjiv Shah at AHA 2017.

Bariatric Surgery in Obese Patients with HTN

Dr. C. Michael Gibson discusses the trial findings with Dr. Carlos Schiavon at AHA 2017

Effects of Exenatide in Type 2 DM and CVD

Dr. C. Michael Gibson discusses the trial findings with Dr. Robert Mentz at AHA 2017

Outcomes with Primary Angioplasty and Prasugrel vs Ticagrelor

Dr. C. Michael Gibson discusses the trial findings with Dr. Zuzana Motovska and Dr. Ota Hlinomaz at AHA 2017

TRICS III – Transfusion Triggers in Cardiac Surgery

Dr. Mathieu Kerneis discusses the trial findings with Dr. David Mazer at AHA 2017

Temporary Neurotoxin Treatment to Prevent Postop AFib

Dr. C. Michael Gibson discusses the trial findings with Dr. Nathan Waldron at AHA 2017

ALLSTAR: ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration

Dr. Timothy Henry and Dr. C. Michael Gibson Discuss

STEMI ACCELERATOR-2 – Regional STEMI Systems of Care

Dr. Christopher Granger, Dr. James Jollis and Dr. C. Michael Gibson Discuss

Opportunities to Improve Outcomes for CV Emergencies in the US

Ms. Mayme Roettig, Dr. James Jollis, Dr. Christopher Granger, Dr. Timothy Henry and Dr. C. Michael Gibson Discuss

BP Measurement in the SBP Intervention Trial

Dr. Karen Johnson and Dr. C. Michael Gibson Discuss

Continued versus Interrupted NOAC at the time of Device Surgery

Dr. David Birnie and Dr. C. Michael Gibson Discuss

Critical Analysis from the CANTOS Trial

Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: CANTOS – Residual Inflammatory Risk and Residual Cholesterol Risk

Does High-Intensity Pitavastatin Therapy Improve Clinical Outcomes?

Dr. Takeshi Kimura and Dr. C. Michael Gibson Discuss REAL-CAD – Does High-Intensity Pitavastatin Therapy Further Improve Clinical Outcomes?